Lithuanian SME Biotechpharma would like to express an interest in Horizon 2020 program and would like to offer our expertise as R&D/GMP manufacturing partner. We would like to join an international consortium which is focusing on a project in biotechnology field.
Biotechpharma is a vertically integrated CDMO which has its own R&D Centre together with GMP manufacturing facilities. In its facilities Biotechpharma develops pharmaceutical molecules from gene to finished drug products. It has capabilities to produce proteins from microbial (300 L) and mammalian (1000 L) cell lines followed by the purification (at room or +4°C temperature) and Fill&Finish in pre-filled syringes and liquid or freeze dried vials.
BIOTECHPHARMA would like to join the consortiums developing proposals on several topics:
- PHC-32-2014: Advancing bioinformatics to meet biomedical and clinical needs;
- PHC-12-2015: Clinical validation of biomarkers and/or diagnostic medical devices;
- PHC-01-2014: Understanding health, ageing and disease: determinants, risk factors and pathways;
- PHC-13-2014: New therapies for chronic non-communicable diseases;
- PHC-14-2015: New therapies for rare diseases;
- PHC-16-2015: Tools and technologies for advanced therapies;
- PHC-15-2015: Clinical research on regenerative medicine.
Contact: Edvinas Vosylius edvinas.vosylius@biotechpharma.lt
More about Biotechpharma.
